Kristian Humer

Kristian Humer

Director of Finance/CFO at 4D MOLECULAR THERAPEUTICS, INC.

Net worth: 13 264 $ as of 2026-09-29

51 year
Finance
Health Technology
Consumer Services

Profile

Kristian Franz Humer is currently an Independent Director at Faeth Therapeutics, Inc. since 2021 and Chief Financial & Accounting Officer at 4D Molecular Therapeutics, Inc. starting in 2026.
Former roles include Chief Financial, Accounting & Business Officer at Viridian Therapeutics, Inc. from 2021 to 2023; Chief Financial Officer at Foghorn Therapeutics, Inc. from 2024 to 2025; Managing Director at Citigroup Global Markets, Inc. (Broker) from 2016 to 2021; MD-Global Healthcare Banking & Capital Markets at Citigroup, Inc. from 2017 to 2021; Associate Director at UBS Financial Services, Inc. from 2004 to 2006; Vice President at Nomura Asset Management USA, Inc. from 2008 to 2009; Associate at Lehman Brothers Holdings, Inc. (Investment Portfolio) from 2007 to 2008; Associate at Merrill Lynch Ventures LLC from 1998 to 2001.
Education includes an undergraduate degree from The University of Reading in 1998 and an MBA from The Fuqua School of Business.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-03-30 446 ( 0% ) 13 264 $ 2026-09-29

Kristian Humer active positions

CompaniesPositionStart
FAETH THERAPEUTICS, INC. Director/Board Member 2021-07-29
4D MOLECULAR THERAPEUTICS, INC. Director of Finance/CFO 2025-11-16

Former positions of Kristian Humer

CompaniesPositionEnd
FOGHORN THERAPEUTICS INC. Director of Finance/CFO 2025-11-13
VIRIDIAN THERAPEUTICS, INC. Director of Finance/CFO 2023-09-11
Analyst-Equity 2021-06-30
CITIGROUP INC. Corporate Officer/Principal 2021-06-30
Corporate Officer/Principal 2009-11-30
See the detail of Kristian Humer's experience

Education of Kristian Humer

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

96

1st degree connections

12

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies12

Finance

Finance

Finance

Finance

Finance

Consumer Services

Finance

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Kristian Humer